Here, we report the case of a 78-year-old man with a history of coronary artery disease and recent pulmonary embolism being treated with anticoagulant therapy who underwent colonoscopy for hematochezia. A 3-cm non-pedunculated colorectal polyp with with Kudo V pit pattern was observed 5 cm above the dentate line (• " Fig. 1 ). An en bloc endoscopic mucosal resection was performed. Histology revealed adenocarcinoma (pT1 G2 Sm3) with a positive resection margin (0.7 mm) and deep submucosal invasion (1.4 mm). Total body computed tomography (CT) and rectal endoscopic ultrasound (EUS) showed no lymphatic or metastatic disease. Because of the patient's comorbidities, we used the FTRD to achieve an R0 resection (• " Video 1) after he had received antibiotic prophylaxis with an intravenous cephalosporin. The last dose of low-mole- Fig. 2 a) were marked with argon plasma coagulation (APC). The FTRD was mounted on the tip of an operative gastroscope and, through a tissue anchor, the whole scarred lesion was pulled into the cap and a modified 14-mm over-thescope clip (OTSC) was deployed. The pseudopolyp created by the OTSC was resected using the preloaded snare and a standard electrosurgical setting (VIO; ERBE Elektromedizin GmbH, Tübingen, Germany) (• " Fig. 2 b) . The procedure took about 8 minutes and there were no complications. Low-molecular-weight heparin was re-introduced 24 hours after the procedure and the patient was discharged. The full-thickness specimen 15 mm in size (• " Fig. 3 ) was subjected to histological analysis, which revealed no remnant dysplasia (• " Fig. 4) . This outcome was confirmed in the biopsy samples taken from the rectal scar 3 months later (• " Fig. 5 ). EUS and CT further confirmed the absence of any disease, and it was decided that no chemotherapy was required. This case illustrates firstly the feasibility of full-thickness endoscopic resection of early CRC in the distal rectum, where standard surgery would carry considerable risks and require aggressive strategies. Secondly, we evaluated the potential of the novel FTRD in a high risk patient with ongoing anticoagulant therapy, for the first time reporting in detail the longterm clinical and endoscopic outcomes of this advanced endoscopic treatment.
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